Experimental evidence from different studies supports the hypothesis that certain flavonoids may protect against AD, in part by interfering with the generation and assembly of amyloid-β peptides into neurotoxic oligomeric aggregates and also by reducing tau aggregation. The gene discussed is MAPT; the disease is Alzheimer disease.